China Diagnostic Reagent Industry Report, Nov. 2013

Transcription

1 China Diagnostic Reagent Industry Report, Nov. 2013

2 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight and projection on the competitive pattern and key companies in the industry, crucial to the development and implementation of effective business, marketing and R&D programs. REPORT OBJECTIVES To establish a comprehensive, factual, annually updated and costeffective information base on market size, competition patterns, market segments, goals and strategies of the leading players in the market, reviews and forecasts. To assist potential market entrants in evaluating prospective acquisition and joint venture candidates. To complement the organizations internal competitor information gathering efforts with strategic analysis, data interpretation and insight. To suggest for concerned investors in line with the current development of this industry as well as the development tendency. To help company to succeed in a competitive market, and METHODOLOGY Both primary and secondary research methodologies were used in preparing this study. Initially, a comprehensive and exhaustive search of the literature on this industry was conducted. These sources included related books and journals, trade literature, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. Subsequently, telephone interviews or correspondence was conducted with marketing executives etc. Other sources included related magazines, academics, and consulting companies. INFORMATION SOURCES The primary information sources include Company Reports, and National Bureau of Statistics of China etc. Copyright 2012 ResearchInChina understand the size and growth rate of any opportunity.

3 Abstract Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In , the diagnostic reagent market size presented the CAGR of over 15%, hitting RMB13.3 billion with the year-on-year growth rate of 16.7% in Moreover, the market will accelerate its pace in the wake of China s medical reform, enhanced health awareness of people and improved physical examination technology. China Diagnostic Reagent Industry Report, In China, in vitro diagnostic reagents consist of biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and hematology diagnostic reagents. Biochemical and immune diagnostic reagents enjoyed the highest 70% market share together in 2012, which was determined by the domestic medical demand. Chinese economy and the government medical expenditure stay at a low level, which affects the medical diagnosis consumption seriously. From now to the next three years, China will desire regular tests mostly, which have the most demand for biochemical and immune diagnostic reagents. The progress in Chinese diagnosis technology and the increase of high-end consumers will boost the demand for molecular diagnostic reagents and other related reagents. The demand for biochemical and immune diagnostic reagents will occupy 60% in Copyright 2012ResearchInChina

4 By virtue of high performance-price ratio and local advantages, Chinese diagnostic reagent enterprises have broken through the monopolization of foreign brands. However, foreign companies still seize 30-40% market share in China with the technical advantages in medium- and high-end fields as well as the monopoly on instrument + reagent integrated platforms. In China, there are diagnostic reagent enterprises, including the leaders KHB, Da An Gene, Sinocare and Leadman, but their market share was still as low as 3.4%, 2.4%, 2.1% and 2.0% respectively in The report mainly includes the followings: Status quo, market segments, import and export, competition pattern and profitability of Chinese diagnostic reagent market; Development trends of Chinese diagnostic reagent in terms of policies (including medical reform), population structure and detection technology; Operation, diagnostic reagent business and prospect of 11 companies, such as KHB, Da An Gene, Sinocare, Leadman, BioSino Biotechnology and Science. Copyright 2012ResearchInChina

5 1 Overview of Diagnostic Reagent Industry 1.1 Definition 1.2 Classification 1.3 Industry Chain 2 Status Quo of China Diagnostic Reagent Industry 2.1 Overview 2.2 Market Structure 2.3 Import and Export Import Export 2.4 Competition Pattern 2.5 Market Segments Biochemical Diagnostic Reagents Immunodiagnostic Reagents Molecular Diagnostic Reagent Comprehensive In Vitro Diagnostic Reagents 2.6 Profit Level 3 Development Forecast of China Diagnostic Reagent Industry 3.1 Overall Forecast The release of a number of favorable policies is conducive to the development of the diagnostic reagent industry Large population base and enhanced aging promote the growth of the diagnostic reagent market The government's medical and health expenditure keeps increasing The number of outpatients maintains stable growth Great Development Potentials of Detectable Items Market Scale Forecast 3.2 Development Trends of Diagnostic Reagent Industry Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream Industry Concentration Will Increase Enterprises with Complete Product Line Integrating Reagents and Instruments will Win 4 Major Chinese Diagnostic Reagent Enterprises 4.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB) Profile Operation Revenue Structure Gross Margin R & D and Investment Clients In Vitro Diagnostics Business Forecast and Prospect 4.2 Da An Gene Co., Ltd. 4.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 4.4 BioSino Bio-technology and Science Inc. 4.5 Beijing Kinghawk Pharmaceutical Co., Ltd Table of contents 4.6 Livzon Pharmaceutical Group Inc Profile Operation Revenue Structure Gross Margin R & D and Investment Clients Forecast and Prospect 4.8 Changsha Sinocare Inc Profile Operation Revenue Structure Gross Margin R & D and Investment Development Forecast 4.9 Bohui Innovation Technology Co., Ltd Profile Operation Revenue Structure Gross Margin R & D and Investment Clients Development Forecast 4.10 Others Shinva Group Humanwell Healthcare

6 Major In Vitro Diagnostic Reagent Types (by Test Principle or Method) In Vitro Diagnostic Reagent Types and Products (by National Policy) Diagnostic Reagent Industry Chain Revenue of China Biological Product Industry, Chinese In Vitro Diagnostic Reagent Market Size, Chinese In Vitro Diagnostic Reagent Market Structure, 2012 China's Diagnostic Reagent Import Volume, China's Diagnostic Reagent Import Value, China's Diagnostic Reagent Import Price, China's Diagnostic Reagent Import Volume and Value by Country or Region, China's Diagnostic Reagent Export Volume, China's Diagnostic Reagent Export Value, China's Diagnostic Reagent Export Price, Top 10 Export Destinations of Chinese Diagnostic Reagents by Export Volume and Value, Diagnostic Instrument Contrast between Domestic and Foreign Enterprises Competition Pattern of China Diagnostic Reagent Industry Revenue and Market Share of Some Chinese In Vitro Diagnosis Companies, 2012 IVD Gross Margin of Some Chinese Diagnostic Reagent Companies, Major Policies of China Diagnostic Reagent Industry, Population of 65-year-old People and Proportion in Total Population in China, Two-week Prevalence Rate of People at All Ages in China Total Medical & Health Costs and Proportion in GDP in China, Chinese Medical & Health Cost Structure, Number of Hospitals in China, Selected Charts

7 Selected Charts Number of Hospitals in China (by Grade), 2012 Diagnoses of Chinese Hospitals, Chinese In Vitro Diagnostic Reagent Market Size, E In Vitro Diagnostic Reagent Product Structure in China, 2015E Products and Revenue of Major Global Diagnostic Reagent Companies Development Process of Roche Diagnostics Integrated Development Strategy of Global Leading Diagnostic Reagent Companies KHB s Revenue and Net Income, KHB s Operating Revenue (by Product), KHB s Operating Revenue (by Region), KHB s Gross Margin (by Product), R&D Costs and % of Total Revenue of KHB, KHB s New Products, by Jul 2013 KHB s Revenue from Top 5 Clients and % of Total Revenue, Name List and Revenue Contribution of KHB s Top 5 Clients, Name List and Procurement of KHB s Top 5 Suppliers, 2012 KHB s Diagnostic Reagent Revenue Structure, 2012 KHB s Medical Instrument Types and Products, 2012 KHB s Revenue and Net Income, E Revenue and Profit of Da An Gene, Operating Revenue of Da An Gene (by Product), Revenue Structure of Da An Gene (by Region), Gross Margin of Da An Gene (by Product), Name List and Revenue Contribution of Top 5 Clients of Da An Gene, Name List and Procurement of Top 5 Suppliers of Da An Gene, 2012

8 Selected Charts R&D Costs and % of Total Revenue of Da An Gene, Reagent Revenue and Gross Margin of Da An Gene, Instrument Revenue and Gross Margin of Da An Gene, Principal Assets and Business of Da An Gene Industrial Chain Layout of Da An Gene Revenue and Net Income of Da An Gene, E Revenue and Net Income of Fosun Pharmaceutical, Operating Revenue of Fosun Pharmaceutical (by Product), Revenue of Fosun Pharmaceutical (by Region), Gross Margin of Fosun Pharmaceutical (by Product), R&D Costs and % of Total Revenue of Fosun Pharmaceutical, Revenue and Net Income of Fosun Pharmaceutical, E Revenue and Annual Profit of BioSino Bio-technology and Science, R&D Costs and % of Total Revenue of BioSino Bio-technology and Science, Revenue and Profit of BioSino Bio-technology and Science, E Revenue and Net Income of Kinghawk Pharmaceutical, Revenue of Kinghawk Pharmaceutical (by Product), Gross Margin of Kinghawk Pharmaceutical (by Product), Revenue and Net Income of Kinghawk Pharmaceutical, E Livzon s Revenue and Net Income, Livzon s Operating Revenue (by Product), Livzon s Revenue (by Region), Livzon s Gross Margin (by Product), Major Diagnostic Reagent Products of Livzon Revenue and Gross Margin of Livzon s Diagnostic Reagent and Equipment,

9 Selected Charts Livzon s Revenue and Net Income, E Leadman s Revenue and Net Income, Leadman s Operating Revenue (by Product), Leadman s Operating Revenue (by Region), Leadman s Gross Margin (by Product), R&D Costs and % of Total Revenue of Leadman, Leadman s Revenue from Top 5 Clients and % of Total Revenue, Name List and Revenue Contribution of Leadman s Top 5 Clients, Number of Leadman s Dealers, Leadman s Revenue and Net Income, E Sinocare s Revenue and Net Income, Sinocare s Capacity, Output and Sales Volume, Sinocare s Blood Sugar Testing Instrument and Strip Sales Price (by Type), Sinocare s Operating Revenue (by Product), Sinocare s Revenue (by Region), Sinocare s Gross Margin (by Product), R&D Costs and % of Total Revenue of Sinocare, Revenue and Net Income of Sinocare, E Revenue and Net Income of Bohui Innovation, Output, Sales Volume and Inventory of Bohui Innovation, Revenue of Bohui Innovation (by Product), Gross Margin of Bohui Innovation (by Product), R&D Costs and % of Total Revenue of Bohui Innovation, Fund-raising Projects and Capacity of Bohui Innovation

10 Selected Charts Name List, Revenue Breakdown and Percentage of Clients of Bohui Innovation, Revenue and Net Income of Bohui Innovation, E Revenue and Net Income of Shinva, Revenue and Profit of Humanwell Healthcare,

11 How to Buy You can place your order in the following alternative ways: 1.Order online at 2.Fax order sheet to us at fax number: your order to: 4. Phone us at / Choose type of format PDF (Single user license)..2,100 USD Hard copy.. 2,200 USD PDF (Enterprisewide license)... 3,300 USD Party A: Name: Address: Contact Person: Tel Fax Party B: Name: Beijing Waterwood Technologies Co., Ltd (ResearchInChina) Address: Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China Contact Person: Liao Yan Phone: Fax: Bank details: Beneficial Name: Beijing Waterwood Technologies Co., Ltd Bank Name: Bank of Communications, Beijing Branch Bank Address: NO.1 jinxiyuan shijicheng,landianchang,haidian District,Beijing Bank Account No #: Routing No # : Bank SWIFT Code: COMMCNSHBJG Reports will be dispatched immediately once full payment has been received. Payment may be made by wire transfer or credit card via PayPal. Title Format Cost Total

12 About ResearchInChina RICDB service ResearchInChina ( is a leading independent provider of China business intelligence. Our research is designed to meet the diverse planning and information needs of businesses, institutions, and professional investors worldwide. Our services are used in a variety of ways, including strategic planning, product and sales forecasting, risk and sensitivity management, and as investment research. Our Major Activities Multi-users market reports Database-RICDB Custom Research Company Search RICDB ( ), is a visible financial data base presented by map and graph covering global and China macroeconomic data, industry data, and company data. It has included nearly 500,000 indices (based on time series), and is continuing to update and increase. The most significant feature of this base is that the vast majority of indices (about 400,000) can be displayed in map. After purchase of our report, you will be automatically granted to enjoy 2 weeks trial service of RICDB for free. After trial, you can decide to become our formal member or not. We will try our best to meet your demand. For more information, please find at For any problems, please contact our service team at: